Masticationpedia

Difference between revisions of "Physiological Dynamics in Demyelinating Diseases: Unraveling Complex Relationships through Computer Modeling"

Physiological Dynamics in Demyelinating Diseases: Unraveling Complex Relationships through Computer Modeling (view source)

Revision as of 12:24, 20 November 2022

28,952 bytes removed ,  1 year ago
no edit summary
Line 187: Line 187:
Articles from International Journal of Molecular Sciences are provided here courtesy of Multidisciplinary Digital Publishing Institute (MDPI)
Articles from International Journal of Molecular Sciences are provided here courtesy of Multidisciplinary Digital Publishing Institute (MDPI)


 
== Bibliography ==
References
 
1. Virchow R. Uber das ausgebreitete Vorkommen einer dem Nervenmark analogen Substanz in den tierischen Geweben. Virchows Arch. Pathol. Anat. 1854;6:562–572. doi: 10.1007/BF02116709. [CrossRef] [Google Scholar]
2. Stiefel K.M., Torben-Nielsen B., Coggan J.S. Proposed evolutionary changes in the role of myelin. Front. Neurosci. 2013;8 doi: 10.3389/fnins.2013.00202. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
3. Bullock T.H., Moore J.K., Fields R.D. Evolution of myelin sheaths: Both lamprey and hagfish lack myelin. Neurosci. Lett. 1984;48:145–148. doi: 10.1016/0304-3940(84)90010-7. [PubMed] [CrossRef] [Google Scholar]
4. Davis A.D., Weatherby T.M., Hartline D.K., Lenz P.H. Myelin-like sheaths in copepod axons. Nature. 1999;398:571–571. doi: 10.1038/19212. [PubMed] [CrossRef] [Google Scholar]
5. Hartline D.K., Colman D.R. Rapid conduction and the evolution of giant axons and myelinated fibers. Curr. Biol. 2007;17:R29–R35. doi: 10.1016/j.cub.2006.11.042. [PubMed] [CrossRef] [Google Scholar]
6. Arancibia-Carcamo I.L., Attwell D. The node of ranvier in CNS pathology. Acta Neuropathol. 2014;128:161–175. doi: 10.1007/s00401-014-1305-z. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
7. Faisal A.A., White J.A., Laughlin S.B. Ion-channel noise places limits on the miniaturization of the brain’s wiring. Curr. Biol. 2005;15:1143–1149. doi: 10.1016/j.cub.2005.05.056. [PubMed] [CrossRef] [Google Scholar]
8. Babbs C.F., Riyi S. Subtle paranodal injury slows impulse conduction in a mathematical model of myelinated axons. PLoS ONE. 2013;8:e67767. doi: 10.1371/journal.pone.0067767. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
9. Trapp B.D., Nave K.A. Multiple sclerosis: An immune or neurodegenerative disorder? Annu. Rev. Neurosci. 2008;31:247–69. doi: 10.1146/annurev.neuro.30.051606.094313. [PubMed] [CrossRef] [Google Scholar]
10. Compston A., Coles A. Multiple sclerosis. Lancet. 2008;372:1502–1517. doi: 10.1016/S0140-6736(08)61620-7. [PubMed] [CrossRef] [Google Scholar]
11. Ostermann P.O., Westerberg C.E. Paroxysmal attacks in multiple sclerosis. Brain. 1975;98:189–202. doi: 10.1093/brain/98.2.189. [PubMed] [CrossRef] [Google Scholar]
12. Twomey J.A., Espir M.L. Paroxysmal symptoms as the first manifestations of multiple sclerosis. J. Neurol. Neurosurg. Psychiatry. 1980;43:296–304. doi: 10.1136/jnnp.43.4.296. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
13. Seewann A., Vrenken H., van der Valk P., Blezer E.L., Knol D.L., Castelijns J.A., Polman C.H., Pouwels P.J., Barkhof F., Geurts J.J. Diffusely abnormal white matter in chronic multiple sclerosis: Imaging and histopathologic analysis. Arch. Neurol. 2009;66:601–609. doi: 10.1001/archneurol.2009.57. [PubMed] [CrossRef] [Google Scholar]
14. Ceccarelli A., Bakshi R., Neema M. MRI in multiple sclerosis: A review of the current literature. Curr. Opin. Neurol. 2012;25:402–409. doi: 10.1097/WCO.0b013e328354f63f. [PubMed] [CrossRef] [Google Scholar]
15. Moore J.W., Joyner R.W., Brill M.H., Waxman S.D., Najar-Joa M. Simulations of conduction in uniform myelinated fibers. Relative sensitivity to changes in nodal and internodal parameters. Biophys. J. 1978;21:147–160. doi: 10.1016/S0006-3495(78)85515-5. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
16. Waxman S.G., Kocsis J.D., Stys P.K. The Axon: Structure, Function and Pathophysiology. Oxford University Press; New York, NY, USA: 1995. [Google Scholar]
17. Polman C.H., Reingold S.C., Banwell B., Clanet M., Cohen J.A., Filippi M., Fujihara K., Havrdova E., Hutchinson M., Kappos L., et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann. Neurol. 2011;69:292–302. doi: 10.1002/ana.22366. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
18. Stephanova D.I., Dimitrov B. Computational Neuroscience: Simulated Demyelinating Neuropathies and Neuronopathies. CRC Press; Boca Raton, FL, USA: 2013. [Google Scholar]
19. Bostock H., Baker M., Reid G. Changes in excitability of human motor axons underlying post-ischaemic fasciculations: Evidence for two stable states. J. Physiol. 1991;441:537–557. doi: 10.1113/jphysiol.1991.sp018766. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
20. Mogyoros I., Kiernan M.C., Burke D., Bostock H. Strength-duration properties of sensory and motor axons in amyotrophic lateral sclerosis. Brain. 1998;121:851–859. doi: 10.1093/brain/121.5.851. [PubMed] [CrossRef] [Google Scholar]
21. Kiernan M.C., Burke D., Andersen K.V., Bostock H. Multiple measures of axonal excitability: A new approach in clinical testing. Muscle Nerve. 2000;23:399–409. doi: 10.1002/(SICI)1097-4598(200003)23:3<399::AID-MUS12>3.0.CO;2-G. [PubMed] [CrossRef] [Google Scholar]
22. Cappelen-Smith C., Kuwabara S., Lin C.S., Mogyoros I., Burke D. Membrane properties in chronic inflammatory demyelinating polyneuropathy. Brain. 2001;124:2439–2447. doi: 10.1093/brain/124.12.2439. [PubMed] [CrossRef] [Google Scholar]
23. Kuwabara S., Ogawara K., Sung J.Y., Mori M., Kanai K., Hattori T., Yuki N., MLin C.S., Burke D., Bostock H. Differences in membrane properties of axonal and demyelinating Guillain-Barré syndromes. Ann. Neurol. 2002;52:180–187. doi: 10.1002/ana.10275. [PubMed] [CrossRef] [Google Scholar]
24. Nodera H., Bostock H., Kuwabara S., Sakamoto T., Asanuma K., Jia-Ying S., Ogawara K., Hattori N., Hirayama M., Sobue G., et al. Nerve excitability properties in Charcot-Marie-Tooth disease type 1A. Brain. 2004;127:203–211. doi: 10.1093/brain/awh020. [PubMed] [CrossRef] [Google Scholar]
25. Sung M.H., Simon R. In silico simulation of inhibitor drug effects on nuclear factor-κB pathway dynamics. Mol. Pharmacol. 2004;66:70–75. doi: 10.1124/mol.66.1.70. [PubMed] [CrossRef] [Google Scholar]
26. Stephanova D.I., Daskalova M. Differences in potentials and excitability properties in simulated cases of demyelinating neuropathies. Part III. Paranodal internodal demyelination. Clin. Neurophysiol. 2005;116:2334–2341. doi: 10.1016/j.clinph.2005.07.013. [PubMed] [CrossRef] [Google Scholar]
27. Stephanova D.I., Daskalova M.S. Differences between the channels, currents and mechanisms of conduction slowing/block and accommodative processes in simulated cases of focal demyelinating neuropathies. Eur. Biophys. J. 2008;37:829–842. doi: 10.1007/s00249-008-0284-1. [PubMed] [CrossRef] [Google Scholar]
28. Stephanova D.I., Alexandrov A.S. Simulating mild systematic and focal demyelinating neuropathies: Membrane property abnormalities. J. Integr. Neurosci. 2006;5:595–623. doi: 10.1142/S0219635206001331. [PubMed] [CrossRef] [Google Scholar]
29. Stephanova D.I., Daskalova M., Alexandrov A.S. Channels, currents and mechanisms of accommodative processes in simulated cases of systematic demyelinating neuropathies. Brain Res. 2007;1171:138–151. doi: 10.1016/j.brainres.2007.07.029. [PubMed] [CrossRef] [Google Scholar]
30. Stephanova D.I., Krustev S.M., Negrev N., Daskalova M. The myelin sheath aqueous layers improve the membrane properties of simulated chronic demyelinating neuropathies. J. Integr. Neurosci. 2011;10:105–120. doi: 10.1142/S0219635211002646. [PubMed] [CrossRef] [Google Scholar]
31. Stephanova D.I., Alexandrov A.S., Kossev A., Christova L. Simulating focal demyelinating neuropathies: Membrane property abnormalities. Biol. Cybern. 2007;96:195–208. doi: 10.1007/s00422-006-0113-5. [PubMed] [CrossRef] [Google Scholar]
32. Bø L., Geurts J.J., Mörk S.J., van der Valk P. Grey matter pathology in multiple sclerosis. Acta Neurol. Scand. Suppl. 2006;183:48–50. doi: 10.1111/j.1600-0404.2006.00615.x. [PubMed] [CrossRef] [Google Scholar]
33. Geurts J.J., Barkhof F. Grey matter pathology in multiple sclerosis. Lancet Neurol. 2008;7:841–851. doi: 10.1016/S1474-4422(08)70191-1. [PubMed] [CrossRef] [Google Scholar]
34. Zivadinov R., Pirko I. Advances in understanding gray matter pathology in multiple sclerosis: Are we ready to redefine disease pathogenesis? BMC Neurol. 2012;12 doi: 10.1186/1471-2377-12-9. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
35. Popescu B.F., Lucchinetti C.F. Pathology of demyelinating diseases. Annu. Rev. Pathol. 2012;7:185–217. doi: 10.1146/annurev-pathol-011811-132443. [PubMed] [CrossRef] [Google Scholar]
36. Kurtzke J.F., Beebe G.W., Nagler B., Nefzger M.D., Auth T.L., Kurland L.T. Studies on the natural history of multiple sclerosis: V. Long-term survival in young men. Arch. Neurol. 1970;22:215–225. doi: 10.1001/archneur.1970.00480210025003. [PubMed] [CrossRef] [Google Scholar]
37. Rao S.M., Leo G.J., Bernardin L., Unverzagt F. Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Neurology. 1991;41:685–691. doi: 10.1212/WNL.41.5.685. [PubMed] [CrossRef] [Google Scholar]
38. Meuth S.G., Bittner S., Ulzheimer J.C., Kleinschnitz C., Kieseier B.C., Wiendl H. Therapeutic approaches to multiple sclerosis: An update on failed, interrupted, or inconclusive trials of neuroprotective and alternative treatment strategies. BioDrugs. 2010;24:317–330. doi: 10.2165/11537190-000000000-00000. [PubMed] [CrossRef] [Google Scholar]
39. Goldenberg M.M. Multiple sclerosis review. Pharm. Ther. 2012;37:137–139. [PMC free article] [PubMed] [Google Scholar]
40. Göbel K., Wedell J.H., Herrmann A.M., Wachsmuth L., Pankratz S., Bittner S., Budde T., Kleinschnitz C., Faber C., Wiendl H., et al. 4-Aminopyridine ameliorates mobility but not disease course in an animal model of multiple sclerosis. Exp. Neurol. 2013;248:62–71. doi: 10.1016/j.expneurol.2013.05.016. [PubMed] [CrossRef] [Google Scholar]
41. Krishnan A.V., Kiernan M.C. Sustained-release fampridine and the role of ion channel dysfunction in multiple sclerosis. Mult. Scler. 2013;19:385–391. doi: 10.1177/1352458512463769. [PubMed] [CrossRef] [Google Scholar]
42. Bowe C.M., Kocsis J.D., Targ E.F., Waxman S.G. Physiological effects of 4-aminopyridine on demyelinated mammalian motor and sensory fibers. Ann. Neurol. 1987;22:264–268. doi: 10.1002/ana.410220212. [PubMed] [CrossRef] [Google Scholar]
43. Sakurai M., Kanazawa I. Positive symptoms in multiple sclerosis: Their treatment with sodium channel blockers, lidocaine and mexiletine. J. Neurol. Sci. 1999;162:162–168. doi: 10.1016/S0022-510X(98)00322-0. [PubMed] [CrossRef] [Google Scholar]
44. Mattson M.P., Guthrie P.B., Kater S.B. A role for Na+-dependent Ca2+ extrusion in protection against neuronal excitotoxicity. FASEB J. 1989;3:2519–2526. [PubMed] [Google Scholar]
45. Moll N.M., Rietsch A.M., Thomas S., Ransohoff A.J., Lee J.C., Fox R., Chang A., Ransohoff R.M., Fisher E. Multiple sclerosis normal-appearing white matter: Pathology-imagig correlations. Ann. Neurol. 2011;70:764–773. doi: 10.1002/ana.22521. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
46. Lucchinetti C., Brück W., Parisi J., Scheithauer B., Rodriguez M., Lassmann H. Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination. Ann. Neurol. 2000;47:707–717. doi: 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q. [PubMed] [CrossRef] [Google Scholar]
47. Kassmann C.M., Nave K.A. Oligodendroglial impact on axonal function and survival— A hypothesis. Curr. Opin. Neurol. 2008;21:235–241. doi: 10.1097/WCO.0b013e328300c71f. [PubMed] [CrossRef] [Google Scholar]
48. Scolding N., Franklin R. Axon loss in multiple sclerosis. Lancet. 1998;352:340–341. doi: 10.1016/S0140-6736(05)60463-1. [PubMed] [CrossRef] [Google Scholar]
49. Mi S., Miller R.H., Lee X., Scott M.L., Shulag-Morskaya S., Shao Z., Chang J., Thill G., Levesque M., Zhang M., et al. LINGO-1 negatively regulates myelination by oligodendrocytes. Nat. Neurosci. 2005;8:745–751. doi: 10.1038/nn1460. [PubMed] [CrossRef] [Google Scholar]
50. Bittner S., Ruck T., Schuhmann M.K., Herrmann A.M., Maati H.M., Bobak N., Göbel K., Langhauser F., Stegner D., Ehling P., et al. 2013 Endothelial TWIK-related potassium channel-1 (TREK1) regulates immune-cell trafficking into the CNS. Nat. Med. 2013;19:1161–1165. doi: 10.1038/nm.3303. [PubMed] [CrossRef] [Google Scholar]
51. Viglietta V., Baecher-Allan C., Weiner H.L., Hafler D.A. Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J. Exp. Med. 2004;199:971–999. doi: 10.1084/jem.20031579. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
52. Zajicek J.P., Wing M., Scolding N.J., Compston D.A. Interactions between oligodendrocytes and microglia. A major role for complement and tumour necrosis factor in oligodendrocyte adherence and killing. Brain. 1992;115:1611–1631. [PubMed] [Google Scholar]
53. Nikić I., Merkler D., Sorbara C., Brinkoetter M., Kreutzfeldt M., Bareyre F.M., Brück W., Bishop D., Misgeld T., Kerschensteiner M. A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis. Nat. Med. 2011;17:495–499. doi: 10.1038/nm.2324. [PubMed] [CrossRef] [Google Scholar]
54. Barnett M.H., Prineas J.W. Relapsing and remitting multiple sclerosis: Pathology of the newly forming lesion. Ann. Neurol. 2004;55:458–468. doi: 10.1002/ana.20016. [PubMed] [CrossRef] [Google Scholar]
55. Van der Laan L.J., Ruuls S.R., Weber K.S., Lodder I.J., Döpp E.A., Dijkstra C.D. Macrophage phagocytosis of myelin in vitro determined by flow cytometry: Phagocytosis is mediated by CR3 and induces production of tumor necrosis factor-α and nitric oxide. J. Neuroimmunol. 1996;70:145–152. doi: 10.1016/S0165-5728(96)00110-5. [PubMed] [CrossRef] [Google Scholar]
56. Wang G., Thompson S.M. Maladaptive homeostatic plasticity in a rodent model of central pain syndrome: Thalamic hyperexcitability after spinothalamic tract lesions. J. Neurosci. 2008;28:11959–11969. doi: 10.1523/JNEUROSCI.3296-08.2008. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
57. Coggan J.S., Prescott S.A., Bartol T.M., Sejnowski T.J. Imbalance of ionic conductances contributes to diverse symptoms of demyelination. Proc. Natl. Acad. Sci. USA. 2010;107:20602–20609. doi: 10.1073/pnas.1013798107. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
58. Coggan J.S., Ocker G.K., Sejnowski T.J., Prescott S.A. Explaining pathological changes in axonal excitability through dynamical analysis of conductance-based models. J. Neural Eng. 2011;8 doi: 10.1088/1741-2560/8/6/065002. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
59. Coggan J.S., Prescott S.A., Sejnowski T.J. Cooperativity between remote sites of ectopic spiking allows afterdischarge to be initiated and maintained at different locations. J. Comput. Neurosci. 2015;39:17–28. doi: 10.1007/s10827-015-0562-8. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
60. Aon M.A., Cortassa S., Akar F.G., Brown D.A., Zhou L., O’Rourke B. From mitochondrial dynamics to arrhythmias. Int. J. Biochem. Cell Biol. 2009;41:1940–1948. doi: 10.1016/j.biocel.2009.02.016. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
61. Su K., Bourdette D., Forte M. Mitochondrial dysfunction and neurodegeneration in multiple sclerosis. Front. Physiol. 2013;4 doi: 10.3389/fphys.2013.00169. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
62. Soltesz I., Staley K. Computational Neuroscience in Epilepsy. 1st ed. Elsevier; London, UK: 2008. [Google Scholar]
63. Hodgkin A.L., Huxley A.F. The components of membrane conductance in the giant axon of Loligo. J. Physiol. 1952;116:473–496. doi: 10.1113/jphysiol.1952.sp004718. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
64. Hodgkin A.L., Huxley A.F. Currents carried by sodium and potassium ions through the membrane of the giant axon of Loligo. J. Physiol. 1952;116:449–472. doi: 10.1113/jphysiol.1952.sp004717. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
65. Fitzhugh R. Computation of impulse initiation and saltatory conduction in a myelinated nerve fiber. Biophys. J. 1962;2:11–21. doi: 10.1016/S0006-3495(62)86837-4. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
66. Goldman L., Albus J.S. Computation of impulse conduction in myelinated fibers; theoretical basis of the velocity-diameter relation. Biophys. J. 1968;8:596–607. doi: 10.1016/S0006-3495(68)86510-5. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
67. Frankenhaeuser B., Huxley A.F. The action potential in the myelinated nerve fiber of Xenopus laevis as computed on the basis of voltage clamp data. J. Physiol. 1964;171:302–315. doi: 10.1113/jphysiol.1964.sp007378. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
68. Smith R.S., Koles Z.J. Myelinated nerve fibers: Computed effect of myelin thickness on conduction velocity. Am. J. Physiol. 1970;219:1256–1258. [PubMed] [Google Scholar]
69. Hutchinson N.A., Koles Z.J., Smith R.S. Conduction velocity in myelinated nerve fibres of Xenopus laevis. J. Physiol. 1970;208:279–289. doi: 10.1113/jphysiol.1970.sp009119. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
70. Koles Z.J., Rasminsky M. A computer simulation of conduction in demyelinated nerve fibres. J. Physiol. 1972;227:351–364. doi: 10.1113/jphysiol.1972.sp010036. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
71. Hardy W.L. Propagation speed in myelinated nerve. II. Theoretical dependence on external Na and on temperature. Biophys. J. 1973;13:1071–1089. doi: 10.1016/S0006-3495(73)86046-1. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
72. Schauf C.L., Davis F.A. Impulse conduction in multiple sclerosis: A theoretical basis for modification by temperature and pharmacological agents. J. Neurol. Neurosurg. Psychiatry. 1974;37:152–161. doi: 10.1136/jnnp.37.2.152. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
73. Brill M.H., Waxman S.G., Moore J.W., Joyner R.W. Conduction velocity and spike configuration in myelinated fibres: Computed dependence on internode distance. J. Neurol. Neurosurg. Psychiatry. 1977;40:769–774. doi: 10.1136/jnnp.40.8.769. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
74. Waxman S.G., Brill M.H. Conduction through demyelinated plaques in multiple sclerosis: Computer simulations of facilitation by short internodes. J. Neurol. Neurosurg. Psychiatry. 1978;41:408–416. doi: 10.1136/jnnp.41.5.408. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
75. Wood S.L., Waxman S.G., Kocsis J.D. Conduction of trans of impulses in uniform myelinated fibers: Computed dependence on stimulus frequency. Neuroscience. 1982;7:423–430. doi: 10.1016/0306-4522(82)90276-7. [PubMed] [CrossRef] [Google Scholar]
76. Goldfinger M.D. Computation of high safety factor impulse propagation at axonal branch points. Neuroreport. 2000;11:449–456. doi: 10.1097/00001756-200002280-00005. [PubMed] [CrossRef] [Google Scholar]
77. Blight A.R. Computer simulation of action potentials and afterpotentials in mammalian myelinated axons: The case for a lower resistance myelin sheath. Neuroscience. 1985;15:13–31. doi: 10.1016/0306-4522(85)90119-8. [PubMed] [CrossRef] [Google Scholar]
78. Halter J.A., Clark J.W., Jr. A distributed-parameter model of the myelinated nerve fiber. J. Theor. Biol. 1991;148:345–382. doi: 10.1016/S0022-5193(05)80242-5. [PubMed] [CrossRef] [Google Scholar]
79. Schwarz J.R., Eikhof G. Na currents and action potentials in rat myelinated nerve fibres at 20 and 37 °C. Pflugers Arch. 1987;409:569–577. doi: 10.1007/BF00584655. [PubMed] [CrossRef] [Google Scholar]
80. Stephanova D.I. Myelin as longitudinal conductor: A multi-layered model of the myelinated human motor nerve fibre. Biol. Cybern. 2001;84:301–308. doi: 10.1007/s004220000213. [PubMed] [CrossRef] [Google Scholar]
81. McIntyre C.C., Richardson A.G., Grill W.M. Modeling the excitability of mammalian nerve fibers: Influence of afterpotentials on the recovery cycle. J. Neurophysiol. 2002;87:995–1006. [PubMed] [Google Scholar]
82. Einziger P.D., Livshitz L.M., Mizrahi J. Generalized cable equation model for myelinated nerve fiber. IEEE Trans. Biomed. Eng. 2005;52:1632–1642. doi: 10.1109/TBME.2005.856031. [PubMed] [CrossRef] [Google Scholar]
83. Volman V., Ng L. Primary paranode demyelination modulates slowly developing axonal depolarization in a model of axonal injury. J. Neural Comput. 2014;37:439–457. [PubMed] [Google Scholar]
84. Stephanova D.I., Bostock H. A Distributed-parameter model of the myelinated human motor nerve fibre: Temporal and spatial distributions of action potentials and ionic currents. Biol. Cybern. 1995;73:275–280. doi: 10.1007/BF00201429. [PubMed] [CrossRef] [Google Scholar]
85. Chiu S.Y., Ritchie J.M. On the physiological role of internodal potassium channels and the security of conduction in myelinated nerve fibres. Proc. R. Soc. Lond. B Biol. Sci. 1984;220:415–422. doi: 10.1098/rspb.1984.0010. [PubMed] [CrossRef] [Google Scholar]
86. Brismar T., Schwarz J.R. Potassium permeability in rat myelinated nerve fibres. Acta Physiol. Scand. 1985;124:141–148. doi: 10.1111/j.1748-1716.1985.tb07645.x. [PubMed] [CrossRef] [Google Scholar]
87. Chiu S.Y., Schwarz W. Sodium and potassium currents in acutely demyelinated internodes of rabbit sciatic nerves. J. Physiol. 1987;391:631–649. doi: 10.1113/jphysiol.1987.sp016760. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
88. Baker M., Bostock H., Grafe P., Martius P. Function and distribution of three types of rectifying channel in rat spinal root myelinated axons. J. Physiol. 1987;383:45–67. [PMC free article] [PubMed] [Google Scholar]
89. Röper J., Schwarz J.R. Heterogeneous distribution of fast and slow potassium channels in myelinated rat nerve fibres. J. Physiol. 1989;416:93–110. doi: 10.1113/jphysiol.1989.sp017751. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
90. Bittner S., Meuth S.G. Targeting ion channels for the treatment of autoimmune neuroinflammation. Ther. Adv. Neurol. Disord. 2013;6:322–336. doi: 10.1177/1756285613487782. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
91. Waxman S.G., Ritchie J.M. Molecular dissection of the myelinated axon. Ann. Neurol. 1993;33:121–136. doi: 10.1002/ana.410330202. [PubMed] [CrossRef] [Google Scholar]
92. Bittner S., Budde T., Wiendl H., Meuth S.G. From the background to the spotlight: TASK channels in pathological conditions. Brain Pathol. 2010;20:999–1009. doi: 10.1111/j.1750-3639.2010.00407.x. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
93. Ehling P., Bittner S., Budde T., Wiendl H., Meuth S.G. Ion channels in autoimmune neurodegeneration. FEBS Lett. 2011;585:3836–3842. doi: 10.1016/j.febslet.2011.03.065. [PubMed] [CrossRef] [Google Scholar]
94. Hübel N., Dahlem M.A. Dynamics from seconds to hours in Hodgkin-Huxley model with time-dependent ion concentrations and buffer reservoirs. PLoS Comput. Biol. 2014;10:e1003941. doi: 10.1371/journal.pcbi.1003941. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
95. Ganapathy L., Clark J.W. Extracellular currents and potentials of the active myelinated nerve fibre. Biophys. J. 1987;52:749–761. doi: 10.1016/S0006-3495(87)83269-1. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
96. Prescott S.A. Pathological changes in peripheral nerve excitability. In: Jaeger D., Jung R., editors. Encyclopedia of Computational Neurosci. 1st ed. Springer-Verlag; New York, NY, USA: 2015. [Google Scholar]
97. Barrett E.F., Barrett J.N. Intracellular recording from vertebrate myelinated axons: Mechanism of the depolarizing afterpotential. J. Physiol. 1982;323:117–144. doi: 10.1113/jphysiol.1982.sp014064. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
98. Blight A.R., Someya S. Depolarizing afterpotentials in myelinated axons of mammalian spinal cord. Neuroscience. 1985;15:1–12. doi: 10.1016/0306-4522(85)90118-6. [PubMed] [CrossRef] [Google Scholar]
99. Richardson A.G., McIntyre C.C., Grill W.M. Modelling the effects of electric fields on nerve fibres: Influence of the myelin sheath. Med. Biol. Eng. Comput. 2000;38:438–446. doi: 10.1007/BF02345014. [PubMed] [CrossRef] [Google Scholar]
100. Zlochiver S. Persistent reflection underlies ectopic activity in multiple sclerosis: A numerical study. Biol. Cybern. 2010;102:181–196. doi: 10.1007/s00422-009-0361-2. [PubMed] [CrossRef] [Google Scholar]
101. Ratté S., Zhu Y., Lee K.Y., Prescott S.A. Criticality and degeneracy in injury-induced changes in primary afferent excitability and the implications for neuropathic pain. Elife. 2014;3:e02370. doi: 10.7554/eLife.02370. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
102. Zhu Y., Feng B., Schwartz E.S., Gebhart G.F., Prescott S.A. Novel method to assess axonal excitability using channelrhodopsin-based photoactivation. J. Neurophysiol. 2015;113:2242–2249. doi: 10.1152/jn.00982.2014. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
103. Tagoe T., Barker M., Jones A., Allcock N., Hamann M. Auditory nerve perinodal dysmyelination in noise-induced hearing loss. J. Neurosci. 2014;12:2684–2688. doi: 10.1523/JNEUROSCI.3977-13.2014. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
104. Brown A.M., Hamann M. Computational modeling of the effects of auditory nerve dysmyelination. Front. Neuroanat. 2014;8 doi: 10.3389/fnana.2014.00073. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
105. Stephanova D.I., Daskalova M. Electrotonic potentials in simulated chronic inflammatory demyelinating polyneuropathy at 20 °C–42 °C. J. Integr. Neurosci. 2015;27:1–18. doi: 10.1142/S0219635215500119. [PubMed] [CrossRef] [Google Scholar]
106. Rasminsky M. Hyperexcitability of pathologically myelinated axons and positive symptoms in multiple sclerosis. Adv. Neurol. 1981;31:289–297. [PubMed] [Google Scholar]
107. Ulrich J., Groebke-Lorenz W. The optic nerve in multiple sclerosis: A morphological study with retrospective clinicopathological correlation. Neuro-Ophthalmology. 1983;3:149–159. doi: 10.3109/01658108309009732. [CrossRef] [Google Scholar]
108. Hamada M.S., Kole M.H. Myelin loss and axonal ion channel adaptations associated with gray matter neuronal hyperexcitability. J. Neurosci. 2015;35:7272–7786. [PMC free article] [PubMed] [Google Scholar]
109. Yu N., Morris C.E., Joós B., Longtin A. Spontaneous excitation patterns computed for axons with injury-like impairments of sodium channels and Na/K pumps. PLoS Comput. Biol. 2012;8:e1002664. doi: 10.1371/journal.pcbi.1002664. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
110. Lopreore C.L., Bartol T.M., Coggan J.S., Keller D.X., Sosinsky G.E., Ellisman M.H., Sejnowski T.J. Computational modeling of three-dimensional electrodiffusion in biological systems: Application to the node of Ranvier. Biophys. J. 2008;95:2624–2635. doi: 10.1529/biophysj.108.132167. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
111. Broome T.M., Cole.man R.A. A mathematical model of cell death in multiple sclerosis. J. Neurosci. Methods. 2011;201:420–425. doi: 10.1016/j.jneumeth.2011.08.008. [PubMed] [CrossRef] [Google Scholar]
112. Ridsdale R.A., Beniac D.R., Tompkins T.A., Moscarello M.A., Harauz G. Three-dimensional structure of myelin basic protein. II. Molecular modeling and considerations of predicted structures in multiple sclerosis. J. Biol. Chem. 1997;272:4269–4275. doi: 10.1074/jbc.272.7.4269. [PubMed] [CrossRef] [Google Scholar]
113. Pigozzo A.B., Macedo G.C., Santos R.W., Lobosco M. On the computational modeling of the innate immune system. BMC Bioinform. 2013;14 doi: 10.1186/1471-2105-14-S6-S7. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
114. Doerck S., Göbel K., Weise G., Schneider-Hohendorf T., Reinhardt M., Hauff P., Schwab N., Linker R., Mäurer M., Meuth S.G., et al. Temporal pattern of ICAM-I mediated regulatory T cell recruitment to sites of inflammation in adoptive transfer model of multiple sclerosis. PLoS ONE. 2010;5:e15478. doi: 10.1371/journal.pone.0015478. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
115. De Mendizábal N.V., Carneiro J., Solé R.V., Goñi J., Bragard J., Martinez-Forero I., Martinez-Pasamar S., Sepulcre J., Torrealdea J., Bagnato F., et al. Modeling the effector-regulatory T cell cross-regulation reveals the intrinsic character of relapses in Multiple Sclerosis. BMC Syst. Biol. 2011;5 doi: 10.1186/1752-0509-5-114. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
116. Jolivet R., Coggan J.S., Allaman I., Magistretti P.J. Multi-timescale modeling of activity-dependent metabolic coupling in the neuron-glia-vasculature ensemble. PLoS Comput. Biol. 2015;11:e1004036. doi: 10.1371/journal.pcbi.1004036. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
117. Zeis T., Allaman I., Gentner M., Schroder K., Tschopp J., Magistretti P.J., Schaeren-Wiemers N. Metabolic gene expression changes in astrocytes in Multiple Sclerosis cerebral cortex are indicative of immune-mediated signaling. Brain Behav. Immun. 2015;48:315–325. doi: 10.1016/j.bbi.2015.04.013. [PubMed] [CrossRef] [Google Scholar]
Tell us what you think!
Gianni
Editor, Editors, USER, admin, Bureaucrats, Check users, dev, editor, founder, Interface administrators, oversight, Suppressors, Administrators, translator
9,284

edits

Retrieved from "https://www.masticationpedia.org/index.php/Special:MobileDiff/14212"